Mallinckrodt plc, a leading global specialty biopharmaceutical company, has announced a €45million investment to expand its Dublin-based operations. A new state-of-the-art manufacturing facility and office building are to be located at College Business and Technology Park, Blanchardstown, Dublin 15. The development will provide 300 jobs during the two-year construction phase and 45 skilled full-time positions once the construction is completed. Pictured at the announcement in the Shelbourne Hotel were Chief Executive Officer and President of Mallinckrodt, Mark Trudeau and An Tánaiste, Joan Burton TD.
Picture Conor McCabe Photography.